Navigation Links
Final agenda available for CTO and Left Main Summit to be held Feb. 21-23, 2013 in NYC
Date:2/13/2013

WHAT:

The final agenda for the Chronic Total Occlusion and Left Main Summit has been set and is now available at: http://www.complexpci.com/conference/agenda.html.

The three-day conference will feature state-of-the-art technologies, research findings and new developments in therapeutic procedures essential for interventional cardiologists to optimize success in chronic total coronary occlusions and left main coronary interventions. Topics at this year's summit will include:

  • Fundamentals of CTO PCI

  • Complex Retrograde and Antegrade CTO PCI

  • Updates on Global CTO Registries

  • Left Main PCI: Essential Knowledge

  • Left Main Publications and Abstracts

  • Complication Prevention and Management

  • How to Improve Outcomes

  • Live Case Transmissions

  • Edited Taped Case Presentations

WHY:

A complete blockage in the coronary artery lasting more than three months, or chronic total occlusion (CTO), has historically been one of the most challenging types of blockages to treat with an interventional procedure. Leading practitioners of percutaneous coronary intervention (PCI) must become experts at restoring blood flow for patients with chronic total occlusions, and with advanced techniques, success rates greater than 90% may be obtained.

Stenting of the unprotected left main coronary artery has also emerged as a viable alternative to surgery in selected patients but requires a special skill set and understanding of anatomy, imaging, hemodynamic support, and adjunctive devices.

This year's conference will emphasize both advanced techniques and evidence-based medicine, along with live case transmissions featuring the world's leading experts in left main and CTO stenting.

WHEN:

February 21-23, 2013

WHERE:

New York Marriott Marquis Hotel
New York, NY

HOW TO REGISTER:

Media may apply for registration by emailing jromero@crf.org.


'/>"/>

Contact: Judy Romero
jromero@crf.org
Cardiovascular Research Foundation
Source:Eurekalert

Related medicine news :

1. Pixel Film Studios Releases ProDust Composite Footage Package for Final Cut Pro X
2. Finally! An Answer To A Good Nights Sleep
3. ProRain Plugin for Final Cut Pro X Released by Pixel Film Studio Today
4. Final agenda available for CRF sponsored conference on stem cell therapy for heart disease
5. The Final Release of Plexxis Drywall Construction Estimating Software is January, 2013
6. Newly Released ProSkin 2.0 and ProMood Final Cut Pro X Plugins at Pixel Film Studios
7. Study demonstrates that earlier end of life care discussions are linked to less aggressive care in final days of life
8. The cells petrol pump is finally identified
9. Agenda set for upcoming CRF-sponsored conference on stem cell therapy for heart disease
10. Refinery Catalyst Market - New Industry Research Report is Now Available for Pre Order at Transparency Market Research
11. New DIY Custom Clock Now Available at Contemporary Heaven
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:9/19/2017)... ... 19, 2017 , ... The Workgroup for Electronic Data Interchange (WEDI) , ... in healthcare information exchange and a trusted advisor to the U.S. Department of Health ... entitled Barriers to Adoption of the ERA and EFT Transactions . , ...
(Date:9/19/2017)... , ... September 19, 2017 , ... Public outrage over ... pollutants have fallen on deaf ears, leaving the water industry itself to research, develop ... stays ahead of the curve in the field of natural alkaline water ...
(Date:9/19/2017)... ... September 19, 2017 , ... ... announces the launch of its magnesium-based orthopedic medical device, OsteoCrete®. OsteoCrete® bone void ... first in the U.S. to incorporate magnesium, a critical property for bone health ...
(Date:9/19/2017)... , ... September 19, 2017 , ... Ron Norman, CEO ... today the importance of making a distinct rather than generic impression in the job ... to look through a stack of resumes knows that the first impression they give ...
(Date:9/19/2017)... , ... September 19, 2017 , ... ... positively linked to the Certified Emergency Nurse (CEN®) certification according to ... (BCEN). The value of certification study, conducted by the Human Resources Research Organization ...
Breaking Medicine News(10 mins):
(Date:9/6/2017)... NeuroRx, a clinical stage biopharma company developing the first oral ... granted Fast Track status by the US Food and Drug ... by NRX-101 (D-cycloserine + lurasidone). The company will shortly begin ... targeting patients who are admitted to Emergency Departments with ASIB ... ...
(Date:9/5/2017)... 2017 Sapheneia and Scannerside received FDA 510(k) ... is a third-party Vendor neutral CT product that makes ... compliance with current MITA standards. ... solution is specifically designed to provide CT operators, prior ... doses over a predefined threshold. Scannerside Dose Check is ...
(Date:9/5/2017)...  Getinge, a leading global provider of innovative ... program -- "Color for the Kids!" -- to ... by The Children,s Heart Foundation. Pediatric patients and ... encouraged to download a coloring picture at ... the gallery on the website. For each artwork ...
Breaking Medicine Technology: